Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings.
Abbott Laboratories shares were down Wednesdsay morning after the company laid out guidance for the first quarter of the year ...
Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall
Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus ...
FierceBiotech6d
Abbott posts 2024 medical device sales gains following structural heart, CGM launches
For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve ...
360dx6d
Abbott Q4 Diagnostics Revenues up 4 Percent, Excluding COVID-19 Tests
Abbott reported $9.34 billion in diagnostics revenues in 2024, down 7 percent on a reported basis from $9.99 billion in 2023 and down 4 percent on an organic basis. Excluding COVID-19 testing-related ...
Expanding EPD Business Supports ABT Stock Amid Macro Issues
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...
Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript
Welcome to Abbott's fourth quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by ...
Abbott’s First-Quarter Outlook Misses Estimates, Shares Down
Abbott Laboratories is forecasting lower-than-expected first-quarter earnings but full-year profit in line with Wall Street ...
Abbott Laboratories’ Growth Prospects and Market Leadership in MedTech Justify Buy Rating
BTIG analyst Marie Thibault maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...